Achaogen (AKAO) Misses Q2 EPS by 16c

Achaogen (NASDAQ: AKAO) reported Q2 EPS of ($0.78), $0.16 worse than the analyst estimate of ($0.62). Revenue for the quarter came in at $1.27 million versus the consensus estimate of $2.4 million.

Cash, cash equivalents and short-term investments totaled $230.3 million, and restricted cash totaled $12.6 million at June 30, 2017.

For earnings history and earnings-related data on Achaogen (AKAO) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• DA Davidson Reiterates Buy Rating on Boost Run (BRUN)
• InspireMD (NSPR) Tops Q2 EPS by 1c